Bolt Biotherapeutics Inc. (BOLT)
NASDAQ
Bolt Biotherapeutics Inc. Shareholder Equity 2020–2025
Bolt Biotherapeutics Inc. annual/quarterly shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Bolt Biotherapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were 26.5M, a 53.66% decrease year-over-year.
- Bolt Biotherapeutics Inc. shareholder equity for 2025 were 26.5M, a 53.66% decrease from 2024.
- Bolt Biotherapeutics Inc. shareholder equity for 2024 were 57.2M, a 49.27% decrease from 2023.
- Bolt Biotherapeutics Inc. shareholder equity for 2023 were 112.7M, a 34.26% decrease from 2022.
- Bolt Biotherapeutics Inc. shareholder equity for 2022 were 171.5M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Bolt Biotherapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $27 |
| 2024 | $57 |
| 2023 | $113 |
| 2022 | $172 |
| 2021 | $250 |
| 2020 | $-105 |
| Bolt Biotherapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $27 |
| 2024-12-31 | $57 |
| 2023-12-31 | $113 |
| 2022-12-31 | $172 |
| 2021-12-31 | $250 |
| 2020-12-31 | $-105 |
Bolt Biotherapeutics Inc. Shareholder Equity — FAQ
Bolt Biotherapeutics Inc. (BOLT) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BOLT's shareholder equity history?
The chart and table above show Bolt Biotherapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.